RxDoctor Payments Data

Jared Mahylis, MD

Orthopaedic Surgery · Detroit, MINPI 1700185154

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (37.4%), royalties or licence payments and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by FX Shoulder Solutions, Inc at 56.8% of the total. 2025 is the largest year on record at $10,527, 4.9 times the $2,139 reported in 2019.

$42,274in general payments, 2019–2025

Across 93 payments — averaging $454.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • FX Shoulder Solutions, Inc$24K
  • Exactech, Inc.$10K
  • Pinnacle, Inc$3K
  • Medwest Associates$3K
  • Encore Medical, LP$823
  • Arthrex$511
  • plus $1K from 13 others
$7,687in research payments, 2019–2025

Across 3 payments — averaging $2562.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Next Science LLC$7K
  • Advita Ortho, LLC$425

What the payments were for

  • Royalty or licence$6,51715%
  • Consulting fees$15,81837%
  • Speaking & faculty fees$4,25010%
  • Grants$2,0005%
  • Travel & lodging$3,6829%
  • Food & beverage$4,95812%
  • Education$5,04912%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,274 in reported general payments places this provider in the 85th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan →

Medicare billing

Part B allowed, 2024
$99,794
Medicare patients
226
Services billed
865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl107$658
Diclofenac Sodium11$557
Ondansetron OdtOndansetron57$518
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen87$476
Ibuprofen58$351
Gabapentin41$172
Methylprednisolone15$90
Oxycodone Hcl27$90
Dexamethasone19$74
Pregabalin20$66
Cephalexin17$62
Tramadol Hcl15$24

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Detroit

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →